 |
|
Bariatric intervention improves metabolic dysfunction-associated steatohepatitis in patients with obesity: A systematic review and meta-analysis
Juchul Hwang, Hyeyoung Hwang, Hyunjae Shin, Bo Hyun Kim, Seong Hee Kang, Jeong-Ju Yoo, Mi Young Choi, Dong eun Lee, Dae Won Jun, Yuri Cho
Clin Mol Hepatol. 2024;30(3):561-576. Published online 2024 Jun 3 DOI: https://doi.org/10.3350/cmh.2023.0384
|
|
Citations to this article as recorded by
 Serial changes in metabolic dysfunction-associated steatotic liver disease after sleeve gastrectomy and their associations with abdominal adiposity: a prospective cohort study
Chung-Yi Yang, Jian-Han Chen, Chung-Yen Chen, Cheng-Yi Kao, Shiu-Feng Huang, Wen-Yu Chang, Hung-Pin Tu, Jee-Fu Huang, Ming-Lung Yu, Chi-Ming Tai
Surgery for Obesity and Related Diseases.2025; 21(5): 537. CrossRef Bariatric nutrition and evaluation of the metabolic surgical patient: Update to the 2022 Obesity Medicine Association (OMA) bariatric surgery, gastrointestinal hormones, and the microbiome clinical practice statement (CPS)
Sue Benson-Davies, Kirsten Frederiksen, Rutuja Patel
Obesity Pillars.2025; 13: 100154. CrossRef Letter to the editor on “Bariatric intervention improves metabolic dysfunction-associated steatohepatitis in patients with obesity: A systematic review and meta-analysis”
Xiao-Song Li, Xi-Ping Shen, Hang Li
Clinical and Molecular Hepatology.2025; 31(1): e15. CrossRef Correspondence to letter to the editor on “Bariatric intervention improves metabolic dysfunction-associated steatohepatitis in patients with obesity: A systematic review and meta-analysis”
Yuri Cho, Dae Won Jun
Clinical and Molecular Hepatology.2025; 31(1): e103. CrossRef Glucagon like peptide-1 receptor agonists as a promising therapeutic option of metabolic dysfunction associated steatotic liver disease and obesity: hitting two targets with one shot
Eda Kaya, Wing-Kin Syn, Paul Manka
Current Opinion in Gastroenterology.2025; 41(3): 104. CrossRef Perioperative Screening for Metabolic Dysfunction Associated Steatotic Liver Disease in People Undergoing Bariatric Surgery: A Pilot Study
David M. Williams, Thinzar Min, Andrew Beamish, Jeffrey W. Stephens
Obesity Surgery.2025; 35(5): 1963. CrossRef Impact of Severity of Metabolism-Related Fatty Liver Disease Based on Pathologic Grading on Outcomes after Sleeve Gastrectomy
云飞 曲
Journal of Clinical Personalized Medicine.2025; 04(02): 826. CrossRef Cambios biométricos y metabólicos a un año de seguimiento en pacientes con obesidad e hígado graso sometidos a gastroplastia endoscópica en manga-EndoSleeve (método Apollo)
Diego Schwarzstein, Lissette Batista, Patricia Gonçalves, Luis Yip, Leoniana Bustillos, Mar Bacardit, Josep Merlo
Revista de la Sociedad Española de Cirugía de Obesidad y Metabólica y de la Sociedad Española para el Estudio de la Obesidad.2025;[Epub] CrossRef Therapeutic strategies targeting SREBP transcription factors: an update to 2024
Yongdan Wang, Haitao Xiao, Lina Lai, Zuguo Zheng
Acta Materia Medica.2025;[Epub] CrossRef Liver and obesity: a narrative review
Amedeo Lonardo, Ralf Weiskirchen
Exploration of Medicine.2025;[Epub] CrossRef Incretins and MASLD: at the Crossroads of Endocrine and Hepatic Disorders
Marwin A. Farrugia, Enzo Pini, Albert Tran, Nicolas Chevalier, Rodolphe Anty, Philippe Gual
Current Obesity Reports.2025;[Epub] CrossRef Emerging mechanisms of non-alcoholic steatohepatitis and novel drug therapies
Hao CHEN, Yang ZHOU, Haiping HAO, Jing XIONG
Chinese Journal of Natural Medicines.2024; 22(8): 724. CrossRef Weight Loss After Sleeve Gastrectomy According to Metabolic Dysfunction-Associated Steatotic Liver Disease Stage in Patients with Obesity: A Liver Biopsy-Based Prospective Study
José Ignacio Martínez-Montoro, Isabel Arranz-Salas, Carolina Gutiérrez-Repiso, Ana Sánchez-García, Luis Ocaña-Wilhelmi, José M. Pinazo-Bandera, Diego Fernández-García, Araceli Muñoz-Garach, Dieter Morales-García, Miren García-Cortés, Eduardo García-Fuente
Nutrients.2024; 16(22): 3857. CrossRef
|